This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Dosing and Outcomes Study of Erythropoiesis-stimulating Therapies (DOSE): A registry for characterizing anemia management and outcomes in oncology patients

Larholt K, Pashos CL, Wang Q, Bookhart B, McKenzie RS, Piech CT


March 1, 2008
 To report the design, methodology, implementation and initial results of the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry, the first US patient registry to collect and report on practice patterns and outcomes associated with erythropoiesis-stimulating therapy (EST) for anaemia management in oncology patients
North America